Skip to main content

Genetic testing and potential harm: DTC or trust me I’m a doctor?

Recently at a couple of conferences (European Human Genetics conference and Consumer Genetics Conf) there have been various speakers questioning DTC genetics and calling for all health related personal genetics to be delivered through medical practitioners. I argued in the past that unregulated tests delivered through practitioners actually have the potential for more harm, not less. By coincidence last week some discrepancies in a DTC and a via MD test were pointed out to me – and they seem topical.
Breast feeding has many benefits one of which appears to be increased IQ scores – however not all studies agree, some indicating that results may be confounded by maternal intelligence (see Wikipedia). Sometimes inconsistencies in associating an action with an outcome can be resolved by looking at genetic variation (which tends to increase the error bars when not accounted for).
So in 2007 some headlines were made when a study was published by Caspi’s group (PNAS, open access) reporting that there is an increase in IQ but only in infants who were not GG for the FADS2 rs174575 SNP. It seemed like a good study, 2 cohorts whose location could not have been farther apart and nearly 3,000 children tested. The numbers begin to get much smaller though when they are dissected as only approx 8% were homozygous GG:

Interesting results – but just one study and there were some doubts expressed at the time (e.g. “they have a measure of maternal IQ but don't directly include it in the published multiple regression suggests that they tried it, but didn't like the results”)
These are preliminary results but a genetic test is was being offered to medical practitioners to enable “informed decisions” to be made (they don’t cite the study but it must be Caspi). They say:
Genetic testing performed by Existence Genetics enables parents to have access to this extremely useful information about their newborn. Although it may be ideal for most mothers to breastfeed, many are in situations that make the decision not so simple. For example, some women take medications that prevent them from breastfeeding, and others experience pain, poor milk production, and other difficulties.
If the baby doesn’t have this gene then breastfeeding appears to have no effect upon IQ.
Empowered by this groundbreaking research, Existence Genetics now provides women, pediatricians, wet nurses, and lactation consultants with exclusive genetic testing services that will allow them to make a more informed decision about breastfeeding.
Infants who have a specific version of the FADS2 gene will have an increase of approximately 7 IQ points, whereas infants without the variant won’t experience any IQ boost from breastfeeding.
Clearly the only influence that this result could have would be to make it easier for mothers not to breastfeed if there is no IQ benefit. Mothers of FADS2 GG babies will be told that breastfeeding will not increase IQ, there is no difference.
Rule No.1: do not base a genetic test on one study, even if it does look compelling. Break this rule at your peril.
Heres why:
Steer CD, Davey Smith G, Emmett PM, Hibbeln JR, Golding J (2010) FADS2 Polymorphisms Modify the Effect of Breastfeeding on Child IQ. PLoS ONE 5(7): e11570.
In a larger study Steer et al attempted replication in 5,394 children. They were not able to reproduce the results, in fact they reported that breastfed GG children performed better by 5.8 IQ points. GG children actually showed the greatest difference.
And another study:

Martin NW, Benyamin B, Hansell NK, Montgomery GW, Martin NG, Wright MJ, Bates TC. Cognitive function in adolescence: testing for interactions between breast-feeding and FADS2 polymorphisms. J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):55-62.e4. Epub 2010 Dec 3.
They also were unable to repeat the Caspi study – unadjusted data showed a benefit if breastfeeding across all genotypes although they also say that when adjusted for sex, SES, paternal and maternal education, and birth weight the significance disappeared – they support the hypothesis that the breastfeeding/IQ association “reflects variation in parental cognitive ability” – in any case there was no FADS2 GG effect.
Based on the follow-up studies there is no support for any personalised advice based on the FADS2 gene – it cannot be used as a reason not to breastfeed and the largest study actually showed increased benefits for IQ in the group that would be advised that not breastfeeding makes no difference
This same doubtful information is also delivered by 23andme: just one study and no mention of the two larger studies. It is though announced as a “preliminary research report”.
I am disappointed that 23andme have not caught the other 2 papers – do they not have an army of researchers keeping up to date? It’s an enormously emotive subject and thus very important, it suggests that they need to improve their literature update methods and I hope they will – try using the “alert me when this article is cited” feature common to almost all journals.
This is does not particularly look good for either of the companies, but there is a big difference – one is delivered by the healthcare practitioner as “useful information” to help you decide to not breastfeed, the other is presented as results of a study. Neither are justified but I would say that the potential for a harmful impact is increased in one of the situations rather than the other. Which has the potential for more harm? Even if you are of the opinion that both are equally harmful, it certainly does not support the claims that because DTC could be harmful it should be banned and all delivered through medical practitioners because that would protect the patient. My view is that DTC or MD is not the problem – transparency is.
I suppose FADS2 is an appropriate name at least
Caspi A, Williams B, Kim-Cohen J, Craig IW, Milne BJ, Poulton R, Schalkwyk LC, Taylor A, Werts H, & Moffitt TE (2007). Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proceedings of the National Academy of Sciences of the United States of America, 104 (47), 18860-5 PMID: 17984066


  1. Breastfeeding is indeed a very emotive subject, and IQ is only one of the claimed benefits. It has also been studied with respect to obesity, eczema, chest/ear infections, plus benefits for mother (lowers risk breast/ovarian cancer).

    Each individual genotype will have some beneficial variants and some less so and untangling each contribution may not be worth much.

    Also, it is risky to make mothers feel guilty for not being able to breastfeed - postnatal depression is worse for mother and baby than formula milk.

  2. Thanks Elaine - that's a very good point about a potential negative aspect of breastfeeding - it makes it all the more important that any information used to formulate advice must be thoroughly researched.

  3. Thanks for sharing this great article.Great information thanks a lot for the detailed article.That is very interesting I love reading and I am always searching for informative information like this.
    pharmacogenetics testing

  4. The most important question is who does genetic testing. This blog explain the importance of genetic testing and how it helps. Thanks

  5. This is a great inspiring article.I am pretty much pleased with your good work.You put really very helpful information. Keep it up. Keep blogging. Looking to reading your next post. Sheldon's Jacket

  6. Great information about wilderness for beginners giving the opportunity for new people.
    valorant phoenix jacket

  7. Our the purpose is to share the reviews about the latest Jackets,Coats and Vests also share the related Movies,Gaming, Casual,Faux Leather and Leather materials available Peaky Blinders Coat

  8. Our the purpose is to share the reviews about the latest Jackets,Coats and Vests also share the related Movies,Gaming, Casual,Faux Leather and Leather materials available Peaky Blinders Coat

  9. Nice Blog !
    Here We are Specialist in Manufacturing of Movies, Gaming, Casual, Faux Leather Jackets, Coats And Vests See Cyberpunk 2077 Jacket

  10. The great website and information shared are also very appreciable. Qbook


Post a Comment

Popular posts from this blog

Personal Genetics & Utility: Round 2 – Mind the EGAPP

Yesterday I wrote about the false Family History vs. Personal Genetics battle, today I look at the old chestnut of traditional risk factors. There seems to be a lot of fear among some professions that personal genetics is attempting to take over their jobs – it’s been like this from the beginning mainly due to misunderstanding (wilful or otherwise) exactly what personal genetics is and what it’s role in healthcare can be. The latest salvo is from the EGAPP Working group who published their assessment of genetics vs. traditional risk factors (TRF) in cardiovascular disease risk. They looked at the 9p21 variant as well as 57 other variants in 28 genes associated with CVD and they sought to document “the extent to which genomic profiling alters CVD risk estimation, alone and in combination with traditional risk factors, and the extent to which risk reclassification improves health outcomes”. Some conclusions from EGAPP: The magnitude of net health benefit from use

If You Want to Practice Evidence Based Medicine then… Use the Evidence

Travelling on a train to Scotland, all for the first time: Clinical researcher says:  "Look the cows in Scotland are black!". Physicist replies: "No. Some of the cows in Scotland are black" Mathematician says:   "No, actually in Scotland there is at least one cow black on one side" I’ve written about folic acid, homocysteine and various clinical trials of nutrients in the past. I just want to revisit it briefly because I think there are some seriously wrong messages emerging from the conclusions. For an excellent comment on evidence based recommendations see Colby Vorland . Homocysteine (Hcy) is associated with CVD, may or may not be causal but the evidence is good (Wald et al , BMJ, 2002). Folic acid (Vitamin B9) in reasonable amounts will lower homocysteine  but clinical trials have been carried out, mostly showing not much benefit as far a CVD is concerned. A recent meta-analysis of 8 trials (total 37,485 individuals) seems t